Staff and Users' Experiences of Pharmacy-Based Sexual and Reproductive Health Services: A Qualitative Interview Study from the UK
- PMID: 33153148
- PMCID: PMC7711956
- DOI: 10.3390/pharmacy8040206
Staff and Users' Experiences of Pharmacy-Based Sexual and Reproductive Health Services: A Qualitative Interview Study from the UK
Abstract
Since August 2015, a large range of sexual health and reproductive health services have been provided in more than 120 pharmacies across Birmingham (England). Our study aimed to explore how pharmacy staff and pharmacy users experience delivering or being provided with sexual health and reproductive health services. Between March and September 2019, semi-structured interviews were conducted with 15 pharmacy staff delivering sexual and reproductive health services and 15 people who had used a sexual and reproductive health service at the pharmacy. Interviews were analysed thematically. Pharmacy users found services convenient to use and were largely satisfied with pharmacy staff consultation skills. Staff were motivated to deliver the services, although some felt that they did not receive sufficient recognition for their work. Barriers to pharmacy-based sexual and reproductive health services were identified, including lack of privacy for users, lack of staff and user awareness of the services, lack of trained staff to deliver services and lack of capacity for copper coil insertions in females presenting for emergency contraception. The identification of barriers to effective service provision can be used to improve the delivery of sexual and reproductive health services in pharmacies and lead to a greater uptake.
Keywords: United Kingdom; contraception; pharmacy staff; pharmacy users; public health; qualitative study; service delivery; sexual and reproductive health; sexually transmitted infection(s); thematic analysis.
Conflict of interest statement
J.R. reports personal fees from GSK Pharma, Mycovia and Nabriva Therapeutics, as well as ownership of shares in GSK Pharma and AstraZeneca Pharma; is author of the UK and European Guidelines on Pelvic Inflammatory Disease; is a Member of the European Sexually Transmitted Infections Guidelines Editorial Board; and is a Member of the National Institute for Health Research Funding Committee (Health Technology Assessment programme). He is an NIHR Journals Editor and associate editor of Sexually Transmitted Infections journal. He is an officer of the International Union against Sexually Transmitted Infections (treasurer), and a charity trustee of the Sexually Transmitted Infections Research Foundation.
Figures
Similar articles
-
Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff.Sex Transm Infect. 2019 Nov;95(7):488-495. doi: 10.1136/sextrans-2019-054096. Epub 2019 Aug 5. Sex Transm Infect. 2019. PMID: 31383779
-
Utilisation of pharmacy-based sexual and reproductive health services: a quantitative retrospective study.Sex Transm Infect. 2021 Mar;97(2):126-133. doi: 10.1136/sextrans-2020-054488. Epub 2020 Aug 15. Sex Transm Infect. 2021. PMID: 32817275 Free PMC article.
-
Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.Public Health. 2014 Apr;128(4):309-16. doi: 10.1016/j.puhe.2013.11.001. Epub 2014 Apr 6. Public Health. 2014. PMID: 24713598
-
Provision of contraception after emergency contraception from the pharmacy: evaluating the acceptability of pharmacy for providing sexual and reproductive health services.Public Health. 2016 Jun;135:97-103. doi: 10.1016/j.puhe.2015.11.017. Epub 2016 Jan 11. Public Health. 2016. PMID: 26787315
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
Cited by
-
Uptake and User Characteristics for Pharmacy-Based Contraception and Chlamydia Treatment: A Quantitative Retrospective Study from the UK.Pharmacy (Basel). 2021 Mar 17;9(1):61. doi: 10.3390/pharmacy9010061. Pharmacy (Basel). 2021. PMID: 33802886 Free PMC article.
References
-
- Rowley J., Hoorn S.V., Korenromp E., Low N., Unemo M., Abu-Raddad L.J., Chico R.M., Smolak A., Newman L., Gottlieb S., et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: Global prevalence and incidence estimates, 2016. Bull. World Health Organ. 2019;97:548–562P. doi: 10.2471/BLT.18.228486. - DOI - PMC - PubMed
-
- Stulpin C., Marrazzo J.M. WHO: 1 million new urogenital STIs acquired each day worldwide. Infect. Dis. Child. 2019;32:5.
-
- Aranda K., Coleman L., Sherriff N., Cocking C., Zeeman L., Cunningham E. Listening for commissioning: A participatory study exploring young people’s experiences, views and preferences of school-based sexual health and school nursing. J. Clin. Nurs. 2017;27:375–385. doi: 10.1111/jocn.13936. - DOI - PubMed
-
- Public Health England . Sexually Transmitted Infections and Screening for Chlamydia in England. Public Health England; London, UK: 2018. Health Protection Report Volume 12 Number 20.
LinkOut - more resources
Full Text Sources